We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Encompass Health (EHC) Q3: Wall Street Projections for Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Encompass Health (EHC - Free Report) will announce quarterly earnings of $0.94 per share in its forthcoming report, representing an increase of 9.3% year over year. Revenues are projected to reach $1.33 billion, increasing 10% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
That said, let's delve into the average estimates of some Encompass Health metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Revenues- Inpatient Rehabilitation' at $1.30 billion. The estimate points to a change of +10% from the year-ago quarter.
Analysts forecast 'Revenues- Outpatient and other' to reach $32.97 million. The estimate points to a change of +24.9% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net patient revenue per discharge' of $21,135.79. The estimate is in contrast to the year-ago figure of $20,472.
Based on the collective assessment of analysts, 'Total Discharges' should arrive at 61,412. The estimate is in contrast to the year-ago figure of 57,665.
Over the past month, Encompass Health shares have recorded returns of +0.2% versus the Zacks S&P 500 composite's +2.7% change. Based on its Zacks Rank #2 (Buy), EHC will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into Encompass Health (EHC) Q3: Wall Street Projections for Key Metrics
Analysts on Wall Street project that Encompass Health (EHC - Free Report) will announce quarterly earnings of $0.94 per share in its forthcoming report, representing an increase of 9.3% year over year. Revenues are projected to reach $1.33 billion, increasing 10% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
That said, let's delve into the average estimates of some Encompass Health metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Revenues- Inpatient Rehabilitation' at $1.30 billion. The estimate points to a change of +10% from the year-ago quarter.
Analysts forecast 'Revenues- Outpatient and other' to reach $32.97 million. The estimate points to a change of +24.9% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net patient revenue per discharge' of $21,135.79. The estimate is in contrast to the year-ago figure of $20,472.
Based on the collective assessment of analysts, 'Total Discharges' should arrive at 61,412. The estimate is in contrast to the year-ago figure of 57,665.
View all Key Company Metrics for Encompass Health here>>>
Over the past month, Encompass Health shares have recorded returns of +0.2% versus the Zacks S&P 500 composite's +2.7% change. Based on its Zacks Rank #2 (Buy), EHC will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>